Thus, we speculate that an inhibitor of IL4i1 may be a useful anti-cancer drug, as it may sensitize cancer cells to ferroptotic death by blocking IL4i1-mediated amino acid metabolism. This evidence concerns the gene IL4I1 and cancer.